FDA Approves Nonsteroidal Treatment for Duchenne Muscular Dystrophy
The U.S. Food and Drug Administration (FDA) has granted approval for Duvyzat (givinostat) as an oral medication intended for treating Duchenne Muscular Dystrophy (DMD) in patients aged six years and older.
Source: FDA
Feature
Text
FDA approves DOVATO (DOLUTEGRAVIR/LAMIVUDINE) for adolescents living with HIV
Dolutegravir/lamivudine (Dovato) has received FDA approval for treating HIV-1 infection in adolescents aged 12 years and older weighing at least 55.11 lbs (25 kg), as announced by ViiV Healthcare
Source: FDA
Text
FDA Approves antibiotic Zevtera for three different applications
Today, the U.S. Food and Drug Administration approved Zevtera (ceftobiprole medocaril sodium for injection) for treating Staphylococcus aureus bloodstream infections (SAB), acute bacterial skin and skin structure infections (ABSSSI), and community-acquired bacterial pneumonia (CABP) in adults, as well as pediatric patients aged three months to less than 18 years with CABP
Source: FDA
Text
Paediatrics & Neonatology | Novel Drugs & Emergent Therapeutics Archive 2023
Text
